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The pathogenicity of the two types of Human 
Immunodeficiency Virus (HIV) is very different. When compared 
to HIV-1, HIV-2 exhibits lower plasma viral loads, causes 
asymptomatic infection, and infected individuals can survive 
longer. It is possible that differential cellular restriction factor 
recognition could account for the epidemic HIV-2 versus 
pandemic HIV-1. One of the restriction factors known is the 
deaminase APOBEC3G (A3G). This enzyme has antiviral activity 
against HIV1 that is suppressed by the viral protein Vif.  
Aim: Understand the role of the A3 family members in HIV-2 infection, compare to HIV-1 and characterize the Vif2-
APOBEC3 protein interaction 
[1] Ribeiro, A.C. et al., (2005)  Journal of Virology, 79, p.823-833.  
[2] Reddy, T.R., et al.,  (1995) Journal of Virology, 69(6): p. 3549-3553. 
 
This work was supported by  Egas Moniz, Cooperativa de Ensino Superior, Portugal. 
Bandarra, S.  is  supported  with a PhD fellowship  (SFRH/BD/81921/2011)  from Fundação para a 
Ciência e Tecnologia (FCT), Lisbon, Portugal 
 
HEK 293T 
pcDNA3.1-A3Tag pAS1B–HAVif2 
qt 
Co-transfection Cell Lysis 
Total Protein 
Bradford Method  
Western Blot 
Fig. 1 A) Viral infectivity of HIV-2wt , HIV-1wt, HIV-2Vif and HIV-1Vif produced in the presence or absence of APOBEC3G. 
Values ​​are presented as % of infectivity relative to respective wild type viruses produced in the absence of A3G, defined as 
100% (n ≥ 2). B) Western blot of A3B protein expression in virus-producing cells lysates. C) Viral infectivity of HIV-2 wt and 
HIV-2Vif produced in the presence of different APOBEC.  The viral infectivity of HIV-2wt and HIV-2Vif produced in the 
presence of pcDNA3.1 (as control) was defined as 100%. Columns and error bars represent average ± SD, respectively, from 
n ≥ 2 independent experiments. 
A3C protein is the most sensitive to Vif2-mediated degradation 
Antiviral effects of APOBEC3 members on HIV-2 infectivity Vif2 effects on APOBECs intracellular levels 
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Among several tested APOBEC3: 
A3C seems to be the cellular factor specifically inhibiting HIV-2 as opposed to HIV-1, what is mainly 
inhibited by A3G 
A3G is more efficient at inhibiting HIV-1 than HIV-2 
A3C is the most effective inhibitor of HIV-2 
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Fig. 2 Effect of increasing amounts of Vif2 with constant amounts of APOBEC (A3B, A3G, A3C, and A1, in ratios from 1:1 to 
1:10 APO/Vif2) in transfected HEK 293T cells. A) Representative Western blot for each analyzed APOBEC. B) 3D plot of  
Western blots shown in A, analyzed with Image J software, version 1.47v. Background  was removed and normalized to -
actin expression levels (internal control). APOBEC expression in the absence of Vif2 (1:0) was defined as 100% C) Average 
values of relative amounts of APOBEC in 293T cell lysates from several assays  (A3B and A3G n ≥ 3;. A1 and A3C n = 1).  
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Our previous studies have shown that A3G is less active  in 
inhibition of HIV-2 than HIV-1 [1]. Viral proteins HIV-2Vif and 
HIV-1Vif share only 30% of identity and these viruses show 
differential replication and productive infection capacity in 
several cell lines [1,2], suggesting either different threshold 
requirements for the same cellular factor or the involvement of 
different factors counteracting Vif1 and Vif2 functions. 
A3B levels are not affected by Vif2 
